{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:37:11Z","timestamp":1777462631949,"version":"3.51.4"},"reference-count":64,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"vor","delay-in-days":928,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Economa y Competitividad (MINECO)","doi-asserted-by":"publisher","award":["BIO2013-48788-C2\u20131-R"],"award-info":[{"award-number":["BIO2013-48788-C2\u20131-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Economa y Competitividad (MINECO)","doi-asserted-by":"publisher","award":["BIO2016-76716-R"],"award-info":[{"award-number":["BIO2016-76716-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Economa y Competitividad (MINECO)","doi-asserted-by":"publisher","award":["SAF2016-75277-R"],"award-info":[{"award-number":["SAF2016-75277-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1074\/jbc.ra117.000177","type":"journal-article","created":{"date-parts":[[2017,12,23]],"date-time":"2017-12-23T06:40:48Z","timestamp":1514011248000},"page":"2247-2259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Amino acid residues in HIV-2 reverse transcriptase that restrict the development of nucleoside analogue resistance through the excision pathway"],"prefix":"10.1016","volume":"293","author":[{"given":"Mar","family":"\u00c1lvarez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Nevot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Mendieta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Men\u00e9ndez-Arias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA117.000177_bib1","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1097\/QAD.0b013e32830edd44","article-title":"A call for randomized controlled trials of antiretroviral therapy for HIV-2 infection in West Africa","volume":"22","author":"Gottlieb","year":"2008","journal-title":"AIDS."},{"key":"10.1074\/jbc.RA117.000177_bib2","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/cid\/ciq248","article-title":"Update on human immunodeficiency virus (HIV)-2 infection","volume":"52","author":"Campbell-Yesufu","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1074\/jbc.RA117.000177_bib3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tips.2007.10.013","article-title":"HIV-1 protease inhibitors: effects on HIV-2 replication and resistance","volume":"29","author":"Men\u00e9ndez-Arias","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1074\/jbc.RA117.000177_bib4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.antiviral.2013.12.001","article-title":"Antiretroviral therapy and drug resistance in human immunodeficiency virus type 2 infection","volume":"102","author":"Men\u00e9ndez-Arias","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1074\/jbc.RA117.000177_bib5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1128\/AAC.01004-07","article-title":"Human immunodeficiency virus types 1 and 2 exhibit comparable sensitivities to zidovudine and other nucleoside analog inhibitors in vitro","volume":"52","author":"Smith","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1074\/jbc.RA117.000177_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.antiviral.2013.01.007","article-title":"Molecular basis of human immunodeficiency virus type 1 drug resistance: overview and recent developments","volume":"98","author":"Men\u00e9ndez-Arias","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1074\/jbc.RA117.000177_bib7","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jmb.2008.10.071","article-title":"Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition","volume":"385","author":"Sarafianos","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1074\/jbc.RA117.000177_bib8","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006882","article-title":"HIV-1 reverse transcription","volume":"2","author":"Hu","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1074\/jbc.RA117.000177_bib9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.virusres.2007.12.015","article-title":"Mechanisms of resistance to nucleoside analogue inhibitors of HIV-1 reverse transcriptase","volume":"134","author":"Men\u00e9ndez-Arias","year":"2008","journal-title":"Virus Res."},{"key":"10.1074\/jbc.RA117.000177_bib10","doi-asserted-by":"crossref","first-page":"15908","DOI":"10.1021\/bi981200e","article-title":"Phenotypic mechanism of HIV-1 resistance to 3\u2032-azido-3\u2032-deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase","volume":"37","author":"Arion","year":"1998","journal-title":"Biochemistry."},{"key":"10.1074\/jbc.RA117.000177_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1097-2765(00)80185-9","article-title":"A mechanism of AZT resistance: an increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase","volume":"4","author":"Meyer","year":"1999","journal-title":"Mol. Cell."},{"key":"10.1074\/jbc.RA117.000177_bib12","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1128\/AAC.44.12.3465-3472.2000","article-title":"Differential removal of thymidine nucleotide analogues from blocked DNA chains by human immunodeficiency virus reverse transcriptase in the presence of physiological concentrations of 2\u2032-deoxynucleoside triphosphates","volume":"44","author":"Meyer","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1074\/jbc.RA117.000177_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0022-2836(02)00911-7","article-title":"Multidrug-resistant HIV-1 reverse transcriptase: involvement of ribonucleotide-dependent phosphorolysis in cross-resistance to nucleoside analogue inhibitors","volume":"323","author":"Mas","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1074\/jbc.RA117.000177_bib14","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1128\/AAC.48.3.992-1003.2004","article-title":"Molecular mechanisms of tenofovir resistance conferred by human immunodeficiency virus type 1 reverse transcriptase containing a diserine insertion after residue 69 and multiple thymidine analog-associated mutations","volume":"48","author":"White","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1074\/jbc.RA117.000177_bib15","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1099\/0022-1317-75-5-951","article-title":"Interactions between drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase","volume":"75","author":"Larder","year":"1994","journal-title":"J. Gen. Virol."},{"key":"10.1074\/jbc.RA117.000177_bib16","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1128\/JCM.37.12.4099-4106.1999","article-title":"Mutation patterns of the reverse transcriptase and protease genes in human immunodeficiency virus type 1-infected patients undergoing combination therapy: survey of 787 sequences","volume":"37","author":"Yahi","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"10.1074\/jbc.RA117.000177_bib17","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1128\/AAC.46.5.1540-1545.2002","article-title":"Effects of specific zidovudine resistance mutations and substrate structure on nucleotide-dependent primer unblocking by human immunodeficiency virus type 1 reverse transcriptase","volume":"46","author":"Meyer","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1074\/jbc.RA117.000177_bib18","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1177\/135965350501000702","article-title":"In vitro phenotypic susceptibility to nucleoside reverse transcriptase inhibitors of HIV-2 isolates with the Q151M mutation in the reverse transcriptase gene","volume":"10","author":"Damond","year":"2005","journal-title":"Antivir. Ther."},{"key":"10.1074\/jbc.RA117.000177_bib19","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1128\/JVI.02259-14","article-title":"Mutation V111I in HIV-2 reverse transcriptase increases the fitness of the nucleoside analogue-resistant K65R and Q151M viruses","volume":"89","author":"Deuzing","year":"2015","journal-title":"J. Virol."},{"key":"10.1074\/jbc.RA117.000177_bib20","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1086\/597802","article-title":"Antiretroviral drug resistance in HIV-2: three amino acid changes are sufficient for classwide nucleoside analogue resistance","volume":"199","author":"Smith","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1074\/jbc.RA117.000177_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.virol.2005.03.030","article-title":"Natural resistance of human immunodeficiency virus type 2 to zidovudine","volume":"336","author":"Reid","year":"2005","journal-title":"Virology."},{"key":"10.1074\/jbc.RA117.000177_bib22","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1089\/088922203322230905","article-title":"Pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy","volume":"19","author":"Brandin","year":"2003","journal-title":"AIDS Res. Hum. Retroviruses."},{"key":"10.1074\/jbc.RA117.000177_bib23","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1086\/596504","article-title":"Emergence of multiclass drug-resistance in HIV-2 in antiretroviral-treated individuals in Senegal: implications for HIV-2 treatment in resource-limited West Africa","volume":"48","author":"Gottlieb","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1074\/jbc.RA117.000177_bib24","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1128\/AAC.00154-09","article-title":"Antiretroviral drug resistance in human immunodeficiency virus type 2","volume":"53","author":"Ntemgwa","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1074\/jbc.RA117.000177_bib25","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1371\/journal.ppat.0020010","article-title":"Why do HIV-1 and HIV-2 use different pathways to develop AZT resistance?","volume":"2","author":"Boyer","year":"2006","journal-title":"PLoS Pathog."},{"key":"10.1074\/jbc.RA117.000177_bib26","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1128\/JVI.06597-11","article-title":"HIV-1 and HIV-2 reverse transcriptases: different mechanisms of resistance to nucleoside reverse transcriptase inhibitors","volume":"86","author":"Boyer","year":"2012","journal-title":"J. Virol."},{"key":"10.1074\/jbc.RA117.000177_bib27","doi-asserted-by":"crossref","first-page":"32792","DOI":"10.1074\/jbc.M109.038885","article-title":"Thymidine analogue resistance suppression by V75I of HIV-1 reverse transcriptase: effects of substituting Valine 75 on stavudine excision and discrimination","volume":"284","author":"Matamoros","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.RA117.000177_bib28","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1073\/pnas.92.6.2398","article-title":"Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides","volume":"92","author":"Shirasaka","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.RA117.000177_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016242","article-title":"K70Q adds high-level tenofovir resistance to \u201cQ151M complex\u201d HIV reverse transcriptase through the enhanced discrimination mechanism","volume":"6","author":"Hachiya","year":"2011","journal-title":"PLoS ONE."},{"key":"10.1074\/jbc.RA117.000177_bib30","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/nsmb.1908","article-title":"Structural basis of HIV-1 resistance to AZT by excision","volume":"17","author":"Tu","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1074\/jbc.RA117.000177_bib31","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jmb.2006.09.073","article-title":"Mutational patterns associated with the 69 insertion complex in multi-drug-resistant HIV-1 reverse transcriptase that confer increased excision activity and high-level resistance to zidovudine","volume":"365","author":"Cases-Gonz\u00e1lez","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1074\/jbc.RA117.000177_bib32","doi-asserted-by":"crossref","first-page":"20615","DOI":"10.1074\/jbc.M111.226100","article-title":"Thymidine analogue excision and discrimination modulated by mutational complexes including single amino acid deletions of Asp-67 or Thr-69 in HIV-1 reverse transcriptase","volume":"286","author":"Kisic","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.RA117.000177_bib33","doi-asserted-by":"crossref","first-page":"14410","DOI":"10.1073\/pnas.222366699","article-title":"Structure of HIV-2 reverse transcriptase at 2.35-\u00c5 resolution and the mechanism of resistance to non-nucleoside inhibitors","volume":"99","author":"Ren","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.RA117.000177_bib34","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/prot.21711","article-title":"A Mg2+-induced conformational switch rendering a competent DNA polymerase catalytic complex","volume":"71","author":"Mendieta","year":"2008","journal-title":"Proteins."},{"key":"10.1074\/jbc.RA117.000177_bib35","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1128\/JCM.38.4.1370-1374.2000","article-title":"Emergence of drug resistance mutations in human immunodeficiency virus type 2-infected subjects undergoing antiretroviral therapy","volume":"38","author":"Rod\u00e9s","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"10.1074\/jbc.RA117.000177_bib36","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1177\/135965350400900422","article-title":"Selection of K65R mutation in HIV-2-infected patients receiving tenofovir-containing regimen","volume":"9","author":"Damond","year":"2004","journal-title":"Antivir. Ther."},{"key":"10.1074\/jbc.RA117.000177_bib37","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/jmv.20174","article-title":"High frequency of selection of K65R and Q151M mutations in HIV-2 infected patients receiving nucleoside reverse transcriptase inhibitors containing regimen","volume":"74","author":"Descamps","year":"2004","journal-title":"J. Med. Virol."},{"key":"10.1074\/jbc.RA117.000177_bib38","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/jmv.20296","article-title":"Polymorphism and drug-selected mutations in the reverse transcriptase gene of HIV-2 from patients living in Southeastern France","volume":"75","author":"Colson","year":"2005","journal-title":"J. Med. Virol."},{"key":"10.1074\/jbc.RA117.000177_bib39","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/jac\/dkr164","article-title":"Drug resistance mutations in patients infected with HIV-2 living in Spain","volume":"66","author":"Trevi\u00f1o","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1074\/jbc.RA117.000177_bib40","doi-asserted-by":"crossref","first-page":"42097","DOI":"10.1074\/jbc.M206725200","article-title":"The molecular mechanism of multidrug resistance by the Q151M human immunodeficiency virus type 1 reverse transcriptase and its suppression using \u03b1-boranophosphate nucleotide analogues","volume":"277","author":"Deval","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.RA117.000177_bib41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00126334-200009010-00002","article-title":"Antiviral resistance of biologic HIV-2 clones obtained from individuals on nucleoside reverse transcriptase inhibitor therapy","volume":"25","author":"van der Ende","year":"2000","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1074\/jbc.RA117.000177_bib42","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/00002030-200305230-00003","article-title":"Pathways for the emergence of multi-dideoxynucleoside-resistant HIV-1 variants","volume":"17","author":"Matsumi","year":"2003","journal-title":"AIDS."},{"key":"10.1074\/jbc.RA117.000177_bib43","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1074\/jbc.271.9.4872","article-title":"Human immunodeficiency virus reverse transcriptase\u2013functional mutants obtained by random mutagenesis coupled with genetic selection in Escherichia coli","volume":"271","author":"Kim","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.RA117.000177_bib44","series-title":"HIV Sequence Compendium 2014","year":"2014"},{"key":"10.1074\/jbc.RA117.000177_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/srep44834","article-title":"Fidelity of classwide-resistant HIV-2 reverse transcriptase and differential contribution of K65R to the accuracy of HIV-1 and HIV-2 reverse transcriptases","volume":"7","author":"\u00c1lvarez","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1074\/jbc.RA117.000177_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2016.02.008","article-title":"High fidelity simian immunodeficiency virus reverse transcriptase mutants have impaired replication in vitro and in vivo","volume":"492","author":"Lloyd","year":"2016","journal-title":"Virology."},{"key":"10.1074\/jbc.RA117.000177_bib47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/abio.2001.5045","article-title":"An integrated system to study multiply substituted human immunodeficiency virus type 1 reverse transcriptase","volume":"292","author":"Boretto","year":"2001","journal-title":"Anal. Biochem."},{"key":"10.1074\/jbc.RA117.000177_bib48","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jmb.2005.04.004","article-title":"Suppression of multidrug-resistant HIV-1 reverse transcriptase primer unblocking activity by \u03b1-phosphate-modified thymidine analogues","volume":"349","author":"Matamoros","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1074\/jbc.RA117.000177_bib49","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1128\/AAC.00716-10","article-title":"Mechanisms involved in the selection of HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with nucleoside analogue therapy failure","volume":"54","author":"Betancor","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1074\/jbc.RA117.000177_bib50","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1006\/jmbi.2001.4904","article-title":"The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is affected by the thumb subdomain of the small protein subunits","volume":"311","author":"Sevilya","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1074\/jbc.RA117.000177_bib51","doi-asserted-by":"crossref","first-page":"25988","DOI":"10.1016\/S0021-9258(18)35706-5","article-title":"Mechanism and fidelity of HIV reverse transcriptase","volume":"267","author":"Kati","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.RA117.000177_bib52","doi-asserted-by":"crossref","first-page":"16636","DOI":"10.1021\/bi981830g","article-title":"Studies on the effects of truncating \u03b1-helix E\u2032 of p66 human immunodeficiency virus type 1 reverse transcriptase on template-primer binding and fidelity of DNA synthesis","volume":"37","author":"Men\u00e9ndez-Arias","year":"1998","journal-title":"Biochemistry."},{"key":"10.1074\/jbc.RA117.000177_bib53","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1742-4690-9-68","article-title":"Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir\/emtricitabine therapy","volume":"9","author":"Betancor","year":"2012","journal-title":"Retrovirology."},{"key":"10.1074\/jbc.RA117.000177_bib54","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1093\/emboj\/19.21.5752","article-title":"Role of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance","volume":"19","author":"Mas","year":"2000","journal-title":"EMBO J."},{"key":"10.1074\/jbc.RA117.000177_bib55","doi-asserted-by":"crossref","first-page":"24569","DOI":"10.1074\/jbc.M312658200","volume":"279","author":"Matamoros","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.RA117.000177_bib56","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.1021\/bi962410z","article-title":"Nucleotide-induced stable complex formation by HIV-1 reverse transcriptase","volume":"36","author":"Tong","year":"1997","journal-title":"Biochemistry."},{"key":"10.1074\/jbc.RA117.000177_bib57","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.virol.2012.10.036","article-title":"Generation of a replication-competent chimeric simian-human immunodeficiency virus carrying env from subtype C clinical isolate through intracellular homologous recombination","volume":"436","author":"Fujita","year":"2013","journal-title":"Virology."},{"key":"10.1074\/jbc.RA117.000177_bib58","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1126\/science.2425430","article-title":"Isolation of a new human retrovirus from West African patients with AIDS","volume":"233","author":"Clavel","year":"1986","journal-title":"Science."},{"key":"10.1074\/jbc.RA117.000177_bib59","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0166-0934(88)90134-6","article-title":"Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds","volume":"20","author":"Pauwels","year":"1988","journal-title":"J. Virol. Methods."},{"key":"10.1074\/jbc.RA117.000177_bib60","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jmb.2008.07.030","article-title":"Mechanistic basis of zidovudine hypersusceptibility and lamivudine resistance conferred by the deletion of codon 69 in the HIV-1 reverse transcriptase-coding region","volume":"382","author":"Kisic","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1074\/jbc.RA117.000177_bib61","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1126\/science.282.5394.1669","article-title":"Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance","volume":"282","author":"Huang","year":"1998","journal-title":"Science."},{"key":"10.1074\/jbc.RA117.000177_bib62","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/jcc.540161106","article-title":"Application of the multimolecule and multiconformational RESP methodology to biopolymers: charge derivation for DNA, RNA and proteins","volume":"16","author":"Cieplak","year":"1995","journal-title":"J. Comput. Chem."},{"key":"10.1074\/jbc.RA117.000177_bib63","series-title":"Gaussian 03","author":"Frisch","year":"2004"},{"key":"10.1074\/jbc.RA117.000177_bib64","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1021\/ct3000734","article-title":"Magnesium ion-water coordination and exchange in biomolecular simulations","volume":"8","author":"Alln\u00e9r","year":"2012","journal-title":"J. Chem. Theory Comput."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820316914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820316914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA117.000177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T03:31:06Z","timestamp":1660188666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820316914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":64,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0021925820316914"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra117.000177","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amino acid residues in HIV-2 reverse transcriptase that restrict the development of nucleoside analogue resistance through the excision pathway","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA117.000177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by The American Society for Biochemistry and Molecular Biology, Inc.","name":"copyright","label":"Copyright"}]}}